Jim Cramer Says Stryker (SYK) and Its Orthopedic Peers Are Facing a Real Tough Run

Stryker Corporation (NYSE:SYK) was among the stocks on Jim Cramer’s radar on Mad Money, as he advised investors to care about where a stock is going, not where it has been. Toward the end of the lightning round, a caller asked if the stock is a buy, sell, or hold. In response, Cramer said:

See, I kept thinking that there would be a consolidator and Stryker would do the consolidating and J&J’s spinning off its orthopedics, too. And it has not come true… And I’m kind of bummed because I thought that that group, which was Zimmer, Biomet, and Stryker, I thought they would work out something, and they haven’t, and it’s been a real tough run.

A stock market graph. Photo by energepic.com

Stryker Corporation (NYSE:SYK) supplies medical technologies, including surgical equipment, joint replacement implants, robotic applications, and AI-assisted virtual care platforms. During the episode aired on May 23, 2025, a caller asked about the stock, and Cramer responded:

I like Stryker, but you know, I don’t like it enough. I don’t like it as much as if it was Intuitive Surgical. That’s the one that I thought we should buy. ISRG.

It is worth noting that since the above comment was aired, Stryker Corporation’s (NYSE:SYK) stock has declined by around 17%.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years 

Disclosure: None. Follow Insider Monkey on Google News.